<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04481165</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200104</org_study_id>
    <nct_id>NCT04481165</nct_id>
  </id_info>
  <brief_title>Experience of Adolescents With Anorexia Nervosa Towards Antidepressants</brief_title>
  <acronym>E3A</acronym>
  <official_title>Subjective Experience of Adolescents Suffering From Anorexia Nervosa With Antidepressants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the experience of adolescents suffering from anorexia
      nervosa confronted with the prescription of antidepressants
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In our adolescent psychiatric unit, antidepressant's prescription is common during the care
      pathway for adolescents with anorexia nervosa.

      The literature highlights a paradox between scientific data and clinical practice, based on
      expert consensus. There are a very few qualitative studies in this subject and none of them
      concern adolescents.

      The purpose of this qualitative study is to explore the experience and opinion of adolescents
      suffering from anorexia nervosa confronted with the prescription of antidepressants
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Qualitative data / Experience of taking anidepressants</measure>
    <time_frame>At the time of inclusion (Day 0)</time_frame>
    <description>Subjective experience of adolescents with anorexia nervosa about prescription of antidepressants and their effects will be obtained during the grid interview and through their describing to written questions</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Adolescents Cared for Anorexia Nervosa at La Maison de Solenn, an Adolescent Psychiatric Unit in Cochin Hospital (Paris, France)</condition>
  <arm_group>
    <arm_group_label>Adolescents with anorexia nervosa</arm_group_label>
    <description>Adolescents from 12 to 25 year old, cared for anorexia nervosa at the Maison de Solenn (Cochin hospital, Paris, France) et for whom antidepressive agents have been prescribed</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey</intervention_name>
    <description>Oral interview and written questions</description>
    <arm_group_label>Adolescents with anorexia nervosa</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adolescents (between 12 and 25 years) suffer from anorexia nervosa, at the Maison de
        Solenn, Cochin Hospital, Paris, France
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adolescents aged 12 to 25

          -  Suffering from anorexia nervosa [according to DSM-5 criteria]

          -  Has been prescribed for a type of SSRIs antidepressant (still ongoing or interrupted
             at the time of the interview)

          -  Non-opposition to the study

        Exclusion Criteria:

          -  Atypical eating disorder that do not meet DSM-5 criteria for restrictive anorexia
             nervosa

          -  Body Mass Index &lt; 15

          -  Prescribed for another antidepressant than SSRIs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maude LUDOT, Psychiatrist</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Rose MORO, PU-PH</last_name>
    <role>Study Chair</role>
    <affiliation>APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Corinne BLANCHET, PH</last_name>
    <role>Study Director</role>
    <affiliation>APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jonathan LACHAL, PHU</last_name>
    <role>Study Director</role>
    <affiliation>APHP, Hôpital Cochin, Maison de Solenn, F-75014 Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maude LUDOT, Psychiatrist</last_name>
    <phone>+33158412426</phone>
    <email>maude.ludot@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie BENHAMMANI-GODARD</last_name>
    <phone>+33158411211</phone>
    <email>marie.godard@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Maison de Solenn / Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Maude LUDOT, Psychiatrist</last_name>
      <phone>+33 1 58 41 24 26</phone>
      <email>maude.ludot@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Leblé N, Radon L, Rabot M, Godart N. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants]. Encephale. 2017 Feb;43(1):62-68. doi: 10.1016/j.encep.2016.02.017. Epub 2016 Jul 21. Review. French.</citation>
    <PMID>27452149</PMID>
  </reference>
  <reference>
    <citation>Anderson C, Roy T. Patient experiences of taking antidepressants for depression: a secondary qualitative analysis. Res Social Adm Pharm. 2013 Nov-Dec;9(6):884-902. doi: 10.1016/j.sapharm.2012.11.002. Epub 2012 Dec 4.</citation>
    <PMID>23219056</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 17, 2020</study_first_submitted>
  <study_first_submitted_qc>July 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 22, 2020</study_first_posted>
  <last_update_submitted>July 17, 2020</last_update_submitted>
  <last_update_submitted_qc>July 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anorexia nervosa</keyword>
  <keyword>Adolescents</keyword>
  <keyword>Antidepressive agents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Use of a treatment database, named Actipidos
Interview recording on a Dictaphone [kept all over the study in a locked drawer in a medical office at the Maison de Solenn, and then destroyed].
Verbatim transcription, on a word-formatted file from a computer in a medical office at the Maison de Solenn; computer secured by a password.
Transcripts will be anonymized with an identical number as soon as they are created; no non-anonymized data records will be kept beyond the end of the study.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>6 months after publication</ipd_time_frame>
    <ipd_access_criteria>Interviews will be analysed with a qualitative methodology (Interpretative Phenomenological Analysis)
- Emergent themes will be presented.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

